The state of Oregon currently has 1 active clinical trials seeking participants for Ulcerative Colitis research studies. These trials are conducted in various cities, including Portland, Eugene, Medford and Clackamas.
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recruiting
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis [UC]) in symptomatic remission with moderate to severe endoscopic inflammation despite optimization of index TIM in a real-world setting.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/12/2024
Locations: Oregon Clinic, Portland, Oregon
Conditions: Ulcerative Colitis, Crohn Disease